Tissue Uptake Study and Photodynamic Therapy of Melanoma-Bearing Mice with a Nontoxic, Effective Chlorin

被引:51
作者
Dabrowski, Janusz M. [1 ]
Krzykawska, Martyna [2 ]
Arnaut, Luis G. [3 ,4 ]
Pereira, Mariette M. [3 ]
Monteiro, Carlos J. P. [3 ]
Simoes, Sergio [4 ,5 ]
Urbanska, Krystyna [2 ]
Stochel, Grazyna [1 ]
机构
[1] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland
[2] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland
[3] Univ Coimbra, Dept Chem, P-3004535 Coimbra, Portugal
[4] Luzitin SA, P-3045016 Coimbra, Portugal
[5] Univ Coimbra, Fac Pharm, Cent Unit, P-3000295 Coimbra, Portugal
关键词
anticancer agents; biodistribution; chlorins; photodynamic therapy; photophysics; SINGLET-OXYGEN; IN-VITRO; 5,10,15,20-TETRAKIS(M-HYDROXYPHENYL) BACTERIOCHLORIN; HALOGENATED BACTERIOCHLORINS; QUANTUM YIELDS; PHOTOSENSITIZERS; BIODISTRIBUTION; MECHANISMS; PORPHYRIN; FOSCAN(R);
D O I
10.1002/cmdc.201100186
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chlorins have intense red absorptions and high tumor affinities that make them interesting candidates for photodynamic therapy (PDT) of cancer. This paper reports cytotoxicity, phototoxicity, in vitro cellular uptake, and in vivo biodistribution and PDT efficacy of a synthetic chlorin derivative (TCPCSO3H) towards Cloudman melanoma cells (S91). No cytotoxic effects were observed in vitro at concentrations up to 20 mu m, and no toxicity was observed in vivo in DBA mice with doses up to 2 mg kg(-1). Pharmacokinetics and biodistribution of TCPCSO3H were evaluated in vivo in DBA mice bearing S91 tumors. TCPCSO3H demonstrated preferential accumulation in S91 mouse melanoma, with tumor-to-normal tissue ratios of 5 and 11 for muscle and skin, respectively, 24 h after intravenous injection of 2 mg kg(-1). Photodynamic therapy performed under these conditions with 70 mW cm(-2) diode laser irradiation at 655 nm for 25 min (total light dose=105 J cm(-2)) resulted in scab formation, followed by temporary or permanent (>60 days) tumor remission. According to the Kaplan-Meier analysis, the median survival time of the control group was 9 days, whereas that of the treated group was 38 days.
引用
收藏
页码:1715 / 1726
页数:12
相关论文
共 46 条
[1]   DESIGN OF PORPHYRIN-BASED PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY [J].
Arnaut, Luis G. .
ADVANCES IN INORGANIC CHEMISTRY, VOL 63: INORGANIC PHOTOCHEMISTRY, 2011, 63 :187-233
[2]   Evaluation of the new photosensitizer stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes [J].
Berdugo, Marianne ;
Bejjani, Riad A. ;
Valamanesh, Fatemeh ;
Savoldelli, Michele ;
Jeanny, Jean-Claude ;
Blanc, Dominique ;
Ficheux, Herve ;
Scherz, Avigdor ;
Salomon, Yoram ;
BenEzra, David ;
Behar-Cohen, Francine .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (04) :1633-1644
[3]   Comparative in vitro study on the characteristics of different photosensitizers employed in PDT [J].
Berlanda, Juergen ;
Kiesslich, Tobias ;
Engelhardt, Victoria ;
Krammer, Barbara ;
Plaetzer, Kristjan .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2010, 100 (03) :173-180
[4]   Photophysical properties of 5,10,15,20-tetrakis(m-hydroxyphenyl)porphyrin-(m-THPP), 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC) and 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (m-THPBC):: a comparative study [J].
Bonnett, R ;
Charlesworth, P ;
Djelal, BD ;
Foley, S ;
McGarvey, DJ ;
Truscott, TG .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1999, (02) :325-328
[5]   HYDROPORPHYRINS OF THE MESO-TETRA(HYDROXYPHENYL)PORPHYRIN SERIES AS TUMOR PHOTOSENSITIZERS [J].
BONNETT, R ;
WHITE, RD ;
WINFIELD, UJ ;
BERENBAUM, MC .
BIOCHEMICAL JOURNAL, 1989, 261 (01) :277-280
[6]   Photobleaching of sensitisers used in photodynamic therapy [J].
Bonnett, R ;
Martínez, G .
TETRAHEDRON, 2001, 57 (47) :9513-9547
[7]   Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: Synthesis, solubility, phototoxicity and the effect of serum proteins [J].
Brandis, A ;
Mazor, O ;
Neumark, E ;
Rosenbach-Belkin, V ;
Salomon, Y ;
Scherz, A .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2005, 81 (04) :983-993
[8]   Photodynamic therapy and anti-tumour immunity [J].
Castano, Ana P. ;
Mroz, Pawel ;
Hamblin, Michael R. .
NATURE REVIEWS CANCER, 2006, 6 (07) :535-545
[9]   Mechanisms in photodynamic therapy: Part three- Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction [J].
Castano, Ana P. ;
Demidova, Tatiana N. ;
Hamblin, Michael R. .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2005, 2 (02) :91-106
[10]   Synthesis, photophysical studies and anticancer activity of a new halogenated water-soluble porphyrin [J].
Dabrowski, Janusz M. ;
Pereira, Mariette M. ;
Arnaut, Luis G. ;
Monteiro, Carlos J. P. ;
Peixoto, Andreia F. ;
Karocki, Andrzej ;
Urbanska, Krystyna ;
Stochel, Grazyna .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2007, 83 (04) :897-903